You are here

  • Home
  • Archive
  • Volume 81, Issue 9
  • Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al
Free

Authors

  1. Correspondence to Dr Xenofon Baraliakos, Rheumazentrum Ruhrgebiet, Herne 44649, Germany; baraliakos{at}me.com
View Full Text

Citation

Baraliakos X, Gossec L, McInnes I, et al
Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al
Annals of the Rheumatic Diseases 2022;81:e174.

Publication history

  • Received August 18, 2020
  • Revised August 20, 2020
  • Accepted August 20, 2020
  • First published September 22, 2020.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.